A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 (Vonaprument) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy
A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 (Vonaprument) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy
The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.
Inclusion Criteria:
Exclusion Criteria:
NOTE: Other protocol-defined inclusion and exclusion criteria apply.
Fullerton, California 92835, United States
Mountain View, California 94040, United States
Springfield, Massachusetts 01107, United States
Neubrandenburg, Mecklenburg-Vorpommern 17036, Germany
Sant Cugat del Vallès, 08195, Spain
Greater London, London EC1V 2PD, United Kingdom